Metropolis Health.
Ticker > Company >

Metropolis Health. share price

Metropolis Healthcare Ltd.

NSE: METROPOLIS BSE: 542650 SECTOR: Hospital & Healthcare Services  149k   553   58

1683.40
+6.90 (0.41%)
BSE: 30 May 04:01 PM

Price Summary

Today's High

₹ 1683.45

Today's Low

₹ 1652.05

52 Week High

₹ 2306.85

52 Week Low

₹ 1383.7

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 8720.33 Cr.

Enterprise Value

₹ 8689.87 Cr.

No. of Shares

5.18 Cr.

P/E

69.88

P/B

7.01

Face Value

₹ 2

Div. Yield

0 %

Book Value (TTM)

₹  240.23

CASH

₹ 30.46 Cr.

DEBT

₹ 0 Cr.

Promoter Holding

48.9 %

EPS (TTM)

₹  24.09

Sales Growth

3.51%

ROE

11.87 %

ROCE

18.02%

Profit Growth

-16.59 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Index Presence

The company is present in 19 Indices.

NFTSML250MOMQ100

Nifty Smallcap250 Momentum Quality 100 index
45828.85
  -69.3499999999985 (-0.15109524992265%)

NFTSMLCAP250Q50

Nifty Smallcap250 Quality 50
26961.25
  -78.9000000000015 (-0.291788322180175%)

NIFTY500

Nifty 500
22801.95
  -59.3999999999978 (-0.25982717556049%)

NIFTYMIDSMALL400

Nifty MidSmallcap 400
19591.6
  -0.55000000000291 (-0.0028072467799789%)

NIF500LGMIDSML

Nifty500 LargeMidSmall Equal-Cap Weighted Index
17507.4
  -11.9499999999971 (-0.0682102931900852%)

NIFTYSMALLCAP250

Nifty Smallcap 250
16833.05
  53.5 (0.318840493338612%)

NY500MUL50:25:25

Nifty500 Multicap 50:25:25
15879.4
  -22.2000000000007 (-0.139608592846008%)

NFT500EQUAL

Nifty 500 Equal Weight
14097.95
  -20.0999999999985 (-0.142370936496172%)

NIFTYTOTALMCAP

Nifty Total Market index
12835.2
  -30.75 (-0.239002949646161%)

SHARIAH500

Nifty500 Shariah
7038.05
  -46.4499999999998 (-0.655656715364528%)

SMLCAP

S&P Bse Small Cap
52413.25
  87.5 (0.167221683396801%)

BSE HC

S&P Bse Healthcare
42604.29
  -110.809999999998 (-0.259416459284889%)

BSE500

S&P Bse 500
35815.16
  -118.25 (-0.329080930532333%)

S&P MIDSMLCAP

S&P Bse MidSmallCap
12414.1
  73.2299999999996 (0.593394144821224%)

MSL400

S&P Bse 400 MidSmallCap
11831.65
  -32.3700000000008 (-0.27284175178397%)

BSE1000

Bse 1000
10666.9
  -30.5900000000001 (-0.285954929614329%)

ALLCAP

S&P Bse Allcap
10130.99
  38.3799999999992 (0.380278243189802%)

SHA500

S&P Bse 500 Shariah
9113.66
  125.5 (1.39628133010539%)

SML250

S&P Bse 250 SmallCap
6737.03
  -0.390000000000327 (-0.00578856594958266%)

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year3.51%
3 Year4.7%
5 Year13.68%

Profit Growth

1 Year-16.59%
3 Year-14.07%
5 Year2.7%

ROE%

1 Year11.87%
3 Year18.2%
5 Year22.04%

ROCE %

1 Year18.02%
3 Year23.83%
5 Year29.26%

Debt/Equity

0

Price to Cash Flow

32.42

Interest Cover Ratio

6.7772

CFO/PAT (5 Yr. Avg.)

1.52607430677483

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 48.90 1.18
Dec 2024 49.40 1.18
Sep 2024 49.43 1.18
Jun 2024 49.62 1.18
Mar 2024 49.67 1.18
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has significantly decreased its debt by 82.2923 Cr.
  • Company has been maintaining healthy ROCE of 23.8291666666667% over the past 3 years.
  • Company is virtually debt free.
  • The Company has been maintaining an effective average operating margins of 26.691714158663% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -93.4565 days.
  • The company has a good cash flow management; CFO/PAT stands at 1.52607430677483.

 Limitations

  • The company has shown a poor profit growth of -14.0710416634143% for the Past 3 years.
  • The company has shown a poor revenue growth of 4.70036119491639% for the Past 3 years.
  • The company is trading at a high PE of 69.88.
  • The company is trading at a high EV/EBITDA of 30.4896.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 292.27 286.14 321.57 296.88 311.95
Total Expenditure 218.35 217.87 239.55 231.78 259.21
Operating Profit 73.92 68.27 82.02 65.1 52.74
Other Income 2.02 2.83 3.59 3.03 7.6
Interest 5.65 4.61 4.73 4.49 4.43
Depreciation 25.24 24.76 26.01 26.85 27.28
Exceptional Items 0 0 0 0 0
Profit Before Tax 45.06 41.72 54.87 36.8 28.63
Tax 13.27 10.44 12.6 9.4 4.78
Profit After Tax 31.78 31.28 42.26 27.41 23.85
Adjusted EPS (Rs) 6.2 6.11 8.25 5.35 4.6

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 665.31 961.39 1157.01 1066.04 1103.43
Total Expenditure 489.25 676.52 832.71 794.56 840.03
Operating Profit 176.05 284.87 324.3 271.48 263.39
Other Income 29.32 12.31 16.15 23.72 12
Interest 10.01 11.26 24.54 31.29 27.25
Depreciation 30.85 43.78 60.26 84.96 90.73
Exceptional Items -24.53 0 15.9 0 0
Profit Before Tax 139.99 242.13 271.55 178.95 157.41
Tax 27.94 59.48 72.01 40 41.52
Net Profit 112.05 182.65 199.53 138.95 115.89
Adjusted EPS (Rs.) 22.13 35.73 38.99 27.13 22.62

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 10.13 10.22 10.23 10.24 10.25
Total Reserves 502.26 654.59 828.97 925.77 1020.94
Borrowings 0 0 158.68 30.77 0
Other N/C liabilities 166.3 113.78 333.26 386.48 226.35
Current liabilities 153.67 222.04 347.89 290.5 263.13
Total Liabilities 832.35 1000.63 1679.03 1643.78 1520.67
Assets
Net Block 215.78 307.09 1004.73 1065.77 1120.09
Capital WIP 0 0 0 0 0
Intangible WIP 2.99 0 5.78 19.51 0
Investments 129.78 3.54 36.65 36.65 36.65
Loans & Advances 150.06 67.29 201.44 217.97 59.86
Other N/C Assets 11.67 1.64 16.28 1.21 2.87
Current Assets 322.08 621.06 414.15 302.67 301.2
Total Assets 832.35 1000.63 1679.03 1643.78 1520.67
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 139.99 242.13 271.55 178.95 157.41
Adjustment 49.41 71.33 54.34 96.11 116.52
Changes in Assets & Liabilities 14.34 -22.16 -5.67 6.72 22.34
Tax Paid -47.61 -55.06 -76.17 -44.04 -27.26
Operating Cash Flow 156.13 236.23 244.04 237.74 269.01
Investing Cash Flow -51.13 59.42 -736.21 46.72 -81.51
Financing Cash Flow -46.37 -31.27 171.97 -287.87 -183
Net Cash Flow 58.63 264.38 -320.19 -3.4 4.5

Corporate Actions

Investors Details

PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
promoters 49.67 49.62 49.43 49.40 48.90
ameera sushil shah 0.35 0.35 0.35 0.35 0.35
duru shah family trust 9.69 9.69 9.69 9.68 11.06
metz advisory llp 30.63 30.63 30.62 30.61 30.29
sushil kanubhai shah 2.50 2.45 2.28 2.28 2.25
sushil shah family trust 4.99 4.99 4.99 4.99 4.94
duru sushil shah 1.49 1.49 1.49 1.49 -
PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
investors 50.33 50.38 50.57 50.60 51.10
aditya birla sun life tru... 1.18 - 1.17 1.12 1.54
canara robeco mutual fund... - - 1.21 1.21 1.13
core diagnostics (mauriti... - - - - 1.00
franklin india smaller co... 2.99 3.29 3.04 2.33 2.09
hdfc mutual fund - hdfc f... 6.65 8.99 9.44 9.71 9.64
j p morgan funds 2.22 1.92 1.90 1.71 1.59
jpmorgan indian investmen... 1.39 1.39 1.21 1.20 1.08
kotak small cap fund - - - - 2.92
nippon life india trustee... 2.56 2.29 2.29 2.73 2.28
sbi life insurance co. lt... 2.14 2.16 2.21 2.14 2.11
sundaram mutual fund a/c ... - - - 1.13 1.50
uti value fund - - - - 3.57
llp 0.03 0.01 0.01 0.02 -
uti flexi cap fund - - - 4.60 -
caisse de depot et placem... 1.44 1.44 1.39 - -
fssa indian subcontinent ... 1.14 1.23 1.22 - -
the scottish oriental sma... 1.19 1.19 1.15 - -
uti large cap fund 5.45 5.17 5.02 - -
quant mutual fund - quant... 1.86 - - - -

Annual Reports

Ratings & Research Reports

Company Presentations

Company News

Metropolis Healthcare informs about disclosure 24 May, 2:47 PM Metropolis Health. - Quaterly Results 13 May, 7:28 PM Metropolis Health. - Quaterly Results 13 May, 7:28 PM Metropolis Healthcare’s arm to acquire Dehradun’s leading diagnostic chain 7 Apr, 10:07 AM Metropolis Healthcare informs about disclosure 7 Apr, 9:57 AM Metropolis Healthcare informs about disclosure 28 Mar, 5:02 PM Metropolis Healthcare acquires Core Diagnostics 24 Mar, 2:41 PM Metropolis Healthcare informs about updates on acquisition 22 Mar, 3:30 PM Metropolis Healthcare informs about grant of restrictive stock units 17 Mar, 1:22 PM Metropolis Healthcare’s arm to acquire Agra-based Scientific Pathology 3 Mar, 2:29 PM Metropolis Health. - Quaterly Results 4 Feb, 5:55 PM Metropolis Health. - Quaterly Results 4 Feb, 5:55 PM Metropolis Health. - Quaterly Results 4 Feb, 5:55 PM Metropolis Healthcare informs about analyst meet 4 Feb, 5:22 PM Metropolis Healthcare informs about postal ballot notice 10 Jan, 5:22 PM Metropolis Healthcare informs about trading window closure 31 Dec, 5:25 PM Metropolis Healthcare incorporates wholly owned subsidiary 26 Dec, 9:20 AM Metropolis Healthcare gets nod to acquire 100% stake in Core Diagnostics 9 Dec, 5:48 PM Metropolis Health. - Quaterly Results 8 Nov, 5:57 PM Metropolis Health. - Quaterly Results 8 Nov, 5:57 PM Metropolis Health. - Quaterly Results 8 Nov, 5:57 PM Metropolis Healthcare informs about disclosure 8 Nov, 3:30 PM Metropolis Healthcare informs about disclosure 23 Aug, 2:52 PM Metropolis Healthcare informs about disclosure 21 Aug, 5:17 PM Metropolis Health. - Quaterly Results 10 Aug, 5:54 PM Metropolis Health. - Quaterly Results 10 Aug, 5:54 PM Metropolis Health. - Quaterly Results 10 Aug, 5:54 PM Metropolis Healthcare submits analyst meet intimation 10 Jun, 1:00 PM Metropolis Health. - Quaterly Results 21 May, 5:52 PM Metropolis Health. - Quaterly Results 21 May, 5:52 PM Metropolis Healthcare informs about conference call 16 May, 10:18 AM Metropolis Healthcare informs about board meeting 14 May, 9:45 AM Metropolis Healthcare informs about disclosure 30 Apr, 4:54 PM Metropolis Healthcare reports 15% growth in core business revenue during Q4FY24 12 Apr, 11:53 AM Metropolis Healthcare informs about disclosure 14 Mar, 10:42 AM Metropolis Healthcare informs about disclosure 5 Mar, 5:16 PM Metropolis Healthcare informs about disclosure 29 Feb, 5:13 PM Metropolis Health. - Quaterly Results 2 Feb, 6:28 PM Metropolis Health. - Quaterly Results 2 Feb, 6:28 PM Metropolis Healthcare informs about board meeting 27 Jan, 11:00 AM Metropolis Healthcare informs about clarification on media reports 15 Jan, 9:58 AM Metropolis Health. - Quaterly Results 4 Nov, 6:54 PM Metropolis Health. - Quaterly Results 4 Nov, 6:54 PM Metropolis Health. - Quaterly Results 4 Nov, 6:54 PM Metropolis Healthcare submits intimation of grant of restrictive stock units 4 Nov, 2:19 PM Metropolis Healthcare informs about certificate 12 Oct, 4:59 PM Metropolis Healthcare informs about analyst meet 23 Sep, 12:46 PM Metropolis Healthcare submits disclosure 29 Aug, 11:18 AM Metropolis Healthcare informs about disclosure 28 Aug, 2:30 PM Metropolis Healthcare informs about transcript of conference call 9 Aug, 5:00 PM

Metropolis Health. Stock Price Analysis and Quick Research Report. Is Metropolis Health. an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Metropolis Health. and its performance over the period of time. Metropolis Health. stock price today is Rs 1680.1.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Metropolis Health. cash from the operating activity was Rs 269.0076 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Metropolis Health. has a Debt to Equity ratio of 0 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Metropolis Health. , the EPS growth was -16.6213 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Metropolis Health. has OPM of 23.870358612372 % which is a good sign for profitability.
     
  • ROE: Metropolis Health. have a average ROE of 11.8732 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Metropolis Health. is Rs 1680.1. One can use valuation calculators of ticker to know if Metropolis Health. share price is undervalued or overvalued.
Last Updated on:
Brief about Metropolis Health.

Metropolis Healthcare Ltd. Financials: Check Share price, Balance Sheet, Annual report and Quarterly Results for company analysis

Metropolis Healthcare Ltd. is a leading provider of diagnostic services founded in 1981. As a long-term stock investor, evaluating the company's financial performance through stock analysis is essential to determine its potential investment opportunities. Our Metropolis Healthcare Ltd., stock analysis page, provides in-depth analysis and reliable information on critical areas such as share price, balance sheet, annual report, dividend, quarterly result, stock price, price chart, news, concall, transcripts, investor presentations, promoters, and shareholders.

Metropolis Healthcare Ltd. Share Price:

An analysis of Metropolis Healthcare Ltd.'s share price performance is crucial for long-term investors seeking the best stock analysis options. The company's share price trends over time need to be analyzed for its performance. Our pre-built screening tool enables investors to compare and analyze the company's stock price with its industry peers, making it easier to identify potential investment opportunities. Investors can evaluate the company's performance over the long term, comparing trends and analyzing financial ratios to identify potential opportunities. A stock's share price is determined by a range of factors, such as market sentiment, financial performance, and general economic conditions.

Metropolis Healthcare Ltd. Balance Sheet:

Metropolis Healthcare Ltd. is a growing company with great potential for long-term investment. Analyzing the company's balance sheet is an important indicator of the company's financial health and growth potential. Our screening tool allows investors to evaluate the company's liquidity, debt levels, and relevant ratios, such as the current ratio and quick ratio. The tool also compares the company's balance sheet with industry peers, making it easier for investors to identify potential investment opportunities.

Metropolis Healthcare Ltd. Annual Report:

A thorough analysis of Metropolis Healthcare Ltd.'s annual report enables investors to gain valuable insights into the company's financial performance and strategic initiatives as a long-term investment opportunity. Our analysis page provides investors with access to the company's financial reports as downloadable documents. Furthermore, our premium feature tools, such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont Analysis, provide a comprehensive evaluation of the company's performance and growth potential. Using these tools, investors can conduct a thorough analysis, unlocking valuable insights to inform investment decisions.

Metropolis Healthcare Ltd. Dividend:

Dividend payout history and consistency of Metropolis Healthcare Ltd. is vital for long-term investors seeking stable investment returns. Our stock analysis page provides information on the company's dividend payout history, and our screening tool helps investors analyze its long-term performance and growth potential. Our screening tool also enables investors to evaluate dividend payout trends compared to industry peers, making it easier to identify potential investment opportunities.

Metropolis Healthcare Ltd. Quarterly Result:

Analyzing the company's quarterly results is crucial to determine the company's financial performance and growth potential as a long-term investment opportunity. Our analysis page provides investors with access to the company's quarterly results as downloadable documents. The premium feature tools such as DCF Analysis and Earnings Multiple Approach enable investors to analyze the information provided in the transcripts more comprehensively than otherwise possible.

Metropolis Healthcare Ltd. Stock Price:

Metropolis Healthcare Ltd.'s stock price performance is a crucial factor for investors seeking the best stock analysis options. Our analysis page provides real-time information on the company's stock price trends, enabling investors to evaluate its performance over time. Our screening tool also enables investors to compare the company's share price performance with industry peers, making it easier to identify potential investment opportunities. Our website provides pre-built screening tools to help investors analyze stock prices and performance.

Metropolis Healthcare Ltd. Price Chart:

Our analysis page offers a price chart that visualizes Metropolis Healthcare Ltd.'s stock price trends over time to provide valuable insight into potential investment opportunities. Our screening tool enables investors to evaluate the company's performance over the long term, comparing trends to make informed investment decisions. Investors can evaluate trends and compare Metropolis Healthcare Ltd.’s share price performance with industry peers, assisting them in identifying potential investment opportunities.

Metropolis Healthcare Ltd. News:

Keeping up-to-date with the latest news and developments about Metropolis Healthcare Ltd. is crucial for long-term investors. Our stock analysis page provides timely news articles about the company, enabling investors to stay informed about the company's financial performance and other relevant events that may impact growth potential. By tracking both local and international news, investors gain valuable insights into the company's market performance and potential as a long-term investment opportunity.

Metropolis Healthcare Ltd. Concall Transcripts:

Analyzing Metropolis Healthcare Ltd.'s concall transcripts provides investors with valuable insights into the company's future guidance, strategic initiatives, and financial performance. Our analysis page offers investors access to the company's concall transcripts as downloadable documents, enabling them to make informed investment decisions. The premium feature tools like DCF Analysis and Earnings Multiple Approach help investors analyze the information provided in the transcripts comprehensively.

Metropolis Healthcare Ltd. Investor Presentation:

Metropolis Healthcare Ltd.'s investor presentations provide valuable insights into the company's growth potential as a long-term investment opportunity. Our analysis page offers investors access to the company's investor presentations as downloadable documents, enabling them to analyze the information more comprehensively. The premium feature tools like BVPS Analysis and DuPont Analysis aid investors in evaluating the company's performance and making informed investment decisions.

Metropolis Healthcare Ltd. Promoter and Shareholder Analysis:

Investors require a deep understanding of Metropolis Healthcare Ltd.'s promoters and shareholders to determine the company's potential as a long-term investment opportunity. Ticker analysis page provides information on the company's promoters and shareholders, enabling investors to make informed decisions about their investments. Furthermore, our screening tool analyzes the company's shareholding patterns and provides valuable insights into the company's potential for growth. 

Metropolis Healthcare Share Capital Trends

Metropolis Healthcare's share capital has shown marginal growth from Rs 10.13 Cr in March 2020 to Rs 10.25 Cr by March 2024. This subtle increase implies a stable equity base for the company without significant dilution of shareholdings.

Metropolis Healthcare's Growth in Reserves

The total reserves of Metropolis Healthcare have witnessed significant growth, surging from Rs 502.26 Cr in March 2020 to Rs 1,020.94 Cr by March 2024. This indicates strong internal funding capabilities and an enhanced financial robustness over the years.

Metropolis Healthcare's Debt Management

Initially, Metropolis Healthcare had zero borrowings up to March 2021. However, by March 2022, the borrowings peaked at Rs 158.68 Cr but were considerably reduced to nil by March 2024, highlighting effective debt management and financial prudence.

Analysis of Metropolis Healthcare's Asset Base

The firm's asset base grew substantially from Rs 832.35 Cr in March 2020 to Rs 1,520.67 Cr by March 2024. The major contribution to this increase was the Net Block, which expanded from Rs 215.78 Cr to Rs 1,120.09 Cr, demonstrating significant capital investments in physical assets.

This data is an analysis of the Standalone Balance Sheet of Metropolis Healthcare.

Metropolis Healthcare is part of the evolving healthcare sector, which is gaining increased focus in stock screening platforms due to the sector's growing importance post-pandemic.

Read More
X